Get Started

ALMS

NASD Alumis Inc.
Oct 24, 2026 · 6:24 AM ET EOD Market Closed

$6.78 ↑ +0.00 (+0.00%) Trading Up from the previous close of $6.78, $0.04 below the day’s high of $6.83

YTD change
-30.53%
vs 20-day SMA
-0.62%
vs 200-day SMA
-68.94%

Price ranges

Previous day
$6.48 $6.83
open $6.68 close $6.78
+$0.10 (+1.50%)
Today
$6.48 $6.83
$6.78
Past week
$6.01 $6.95
from $6.31 now $6.78
+$0.47 (+7.45%)
Past month
$6.01 $7.56
from $7.29 now $6.78
-$0.51 (-7.00%)
This year
$6.01 $31.35
from $9.76 now $6.78
-$2.98 (-30.53%)

Price & Performance

-18.15 (-72.80%) / 6M

$4.12$13.49$22.87$32.24Apr 24Jul 27Oct 23

Signals & Sentiment

Momentum, market sentiment, and recent alerts

Neutral
  • The stock is 78.4% away from all-time highs of $31.35
  • ALMS is down 31% since the beginning of the year
  • ALMS is up 47% over the past 12 months
  • ALMS is down 7% over the past 1 month
  • 11% of all ALMS investors are betting against ALMS

ALMS reads neutral: price sits below both the 20- and 200-day averages, the 12-month move is +50.3%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable No
EPS $-1.11
Earnings momentum -48.8% Quarterly EPS growth
Quarterly change -48.8%

Valuation

P/E ratio N/A
Enterprise value $405.0M
Beta -0.36

Balance sheet & scale

IncomeN/A
Revenue$7.4M
Cash$502.3M
Debt$36.4K
Income / Debt N/A

Company & Peers

Company profile and competitor comparison

Company profile

ExchangeNASD
Sector Manufacturing
Sub Sector Chemical Manufacturing
Market cap $877.6M

Alumis, Inc. is a clinical stage biopharmaceutical company, which engages in identifying, acquiring, and accelerating the development and commercialization of transformative medicines for autoimmune disorders. It focuses on building a pipeline of molecules with the potential to address a broad range of immune-mediated diseases such as monotherapy or combination therapies. The company was founded on January 29, 2021 and is headquartered in San Francisco, CA.

Competitor comparison

TickerCompany PriceChange
LLY Eli Lilly and Company $1,273.46 -2.54%
JNJ Johnson & Johnson $263.81 -1.42%
ABBV AbbVie, Inc. $285.64 +0.16%
MRK Merck & Co., Inc. $145.27 -1.34%
RHHBY Roche Holding Ltd Sponsored ADR $61.17 +2.60%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

See plans TI Pro Download

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.